Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
Andrea Russo,1 Nicolò Scaroni,1 Elena Gambicorti,1 Raffaele Turano,1 Francesco Morescalchi,1 Ciro Costagliola,2 Francesco Semeraro1 1Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, 2Eye Clinic, Department of Health Sciences, University of Molis...
Guardado en:
Autores principales: | Russo A, Scaroni N, Gambicorti E, Turano R, Morescalchi F, Costagliola C, Semeraro F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/518ce34b357b4dd59c15b9b40bbc3471 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis D, et al.
Publicado: (2017) -
Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
por: Sagong M, et al.
Publicado: (2021) -
Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
por: Cvetkova NP, et al.
Publicado: (2016) -
One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
por: Hirakata T, et al.
Publicado: (2016) -
ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
por: S. A. Korotkikh, et al.
Publicado: (2016)